Inogen (INGN) Common Equity (2012 - 2026)

Inogen (INGN) has 15 years of Common Equity data on file, last reported at $182.9 million in Q1 2026.

• Quarterly Common Equity fell 7.6% year-over-year to $182.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182.9 million (down 7.6% YoY) and the FY2025 annual result came in at $192.2 million, up 10.57% from the prior year.
• Common Equity fell to $182.9 million in Q1 2026 per INGN's latest filing, from $192.2 million in the prior quarter.
• Across five years, Common Equity topped out at $358.3 million in Q1 2022 and bottomed at $173.9 million in Q4 2024.
• The 5-year median for Common Equity is $199.5 million (2025), against an average of $239.0 million.
• The widest annual swing landed in 2023, when Common Equity tumbled 34.26%; it then advanced 10.57% in 2025.
• Tracing INGN's Common Equity over 5 years: stood at $297.4 million in 2022, then sank by 31.13% to $204.8 million in 2023, then decreased by 15.11% to $173.9 million in 2024, then increased by 10.57% to $192.2 million in 2025, then decreased by 4.85% to $182.9 million in 2026.
• Per Business Quant, the three latest INGN Common Equity figures stand at $182.9 million (Q1 2026), $192.2 million (Q4 2025), and $197.2 million (Q3 2025).

Peer Comparison